Your browser doesn't support javascript.
Immunotherapy is a preferred option for oral cancer patients during COVID-19 pandemic?
Chu, Chen; Sun, Yan; Pan, Yingxiao.
  • Chu C; Department of Stomatology, The Affiliated Hospital of Qingdao University, Qingdao 266000, Shandong, China; School of Stomatology of Qingdao University, Qingdao 266000, Shandong, China.
  • Sun Y; Department of Stomatology, The Affiliated Hospital of Qingdao University, Qingdao 266000, Shandong, China; School of Stomatology of Qingdao University, Qingdao 266000, Shandong, China. Electronic address: sunyan2433@126.com.
  • Pan Y; School of Stomatology of Qingdao University, Qingdao 266000, Shandong, China.
Oral Oncol ; 107: 104860, 2020 08.
Article in English | MEDLINE | ID: covidwho-598539
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Mouth Neoplasms / Coronavirus Infections / Pandemics / Chemoradiotherapy / Betacoronavirus / Antineoplastic Agents, Immunological Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: Oral Oncol Journal subject: Neoplasms Year: 2020 Document Type: Article Affiliation country: J.oraloncology.2020.104860

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Mouth Neoplasms / Coronavirus Infections / Pandemics / Chemoradiotherapy / Betacoronavirus / Antineoplastic Agents, Immunological Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: Oral Oncol Journal subject: Neoplasms Year: 2020 Document Type: Article Affiliation country: J.oraloncology.2020.104860